
RedC Biotech
Developing universal donor-free red blood cells for life-saving transfusions and advanced therapies.
About
RedC Biotech produces proprietary, donor-free, universal red blood cells designed to be suitable for almost every patient. This technology aims to provide unlimited, high-quality, and low-cost blood transfusions for life-saving treatments and advanced therapies, addressing the global shortage and complex supply chain of traditional blood donations.
Similar companies
Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.
Shares Life Sciences, Biotech
AI-powered patient-centric drug simulations to accelerate and de-risk drug development.
Shares Life Sciences, Clinical Trials
AI-powered blood test for early cancer detection and subtyping.
Shares Life Sciences, Biotech
Omnix Medical is developing a novel platform for advanced wound care management.
Shares Life Sciences, HealthTech
Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.
Shares Life Sciences, Biotech
Biotechnology company developing potentially curative cell therapies for cancer patients.
Shares Life Sciences, Biotech
Key facts
- Website
- redcbiotech.com
- Headquarters
- San Diego, United States
- Founded
- 2015
- Employees
- 5
- Business model
- B2B
Tech stack
Detected on redcbiotech.com, last scanned 31 Oct 2026. Run your own scan
- Observability
- Sentry
- CMS / Builders
- Wix
- CDN
- Cloudflare
- Email provider
- Microsoft 365
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is RedC Biotech trustworthy and reputable?
StartupHub's Data Trust & Reputation score for RedC Biotech is 65 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How many employees does RedC Biotech have?
RedC Biotech has approximately 5 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for RedC Biotech:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules


